Investigator
Jonathan Mark Brown
GORDON RESEARCH CONFERENCES · funded by NHLBI, NIAAA
- Companies
- 2
- Grants
- 4
- Non-dilutive funding
- $1.8M
- First award
- May 1, 2016
Resolved onto their grants.
Federal awards on file.
Summed across those awards.
Latest Jun 1, 2026.
Companies from this work
Pre-ticker companies the crosswalk resolved onto a grant filed under this investigator. Momentum shows for the therapeutic areas your seat covers; open a dossier for the full crosswalk.
- GORDON RESEARCH CONFERENCESMomentum in another area
NeuroGrant-only
- SENSORIUM THERAPEUTICS INCMomentum in another area
NeuroGrant-only
Grant record
Federal awards filed under this investigator name, newest first. Each links to the public record where the awarding agency publishes one.
- R13
2026 Lipoprotein Metabolism Gordon Research Conference and Gordon Research Seminar
$25kJun 1, 2026NHLBIGORDON RESEARCH CONFERENCESNIH RePORTER · 11391682 (opens the source filing in a new tab)
- R01
Gut Microbe-Derived Lipids Shape Chronic Inflammation in Cardiometabolic Disease
$743kMay 1, 2025NHLBICLEVELAND CLINIC LERNER COM-CWRUNIH RePORTER · 11163175 (opens the source filing in a new tab)
- R01
Gut Microbe-Derived Lipids Shape Chronic Inflammation in Cardiometabolic Disease
$728kMay 1, 2025NHLBICLEVELAND CLINIC LERNER COM-CWRUNIH RePORTER · 11325047 (opens the source filing in a new tab)
- P50
Project 1 Title: Gut microbial metabolites as drivers of ethanol-induced liver injury
$274kMay 1, 2016NIAAACLEVELAND CLINIC LERNER COM-CWRUNIH RePORTER · 11064843 (opens the source filing in a new tab)
This page aggregates public U.S. federal grant records filed under one investigator name and the companies Biodatica has resolved onto them. Names are shown as the awarding agency filed them; grant awards are non-dilutive federal funding, not equity or valuation. Distinct people who file under the same name would appear together here. It is informational only and not investment advice. Methodology · Data sources